ADXN
Addex Therapeutics
ADXN
ADXN
3 hedge funds and large institutions have $717K invested in Addex Therapeutics in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
$260K |
Top Sellers
| 1 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
$0 |
| 2 |
Jane Street
New York
|
$0 |
| 3 |
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NMC
1
NEA Management Company
Timonium,
Maryland
| $306K | – | – | – |
|
|
AC
2
Armistice Capital
New York
| $260K | +$97.7K | +16,150 | +60% |
|
|
JSC
3
J. Stern & Co
London,
United Kingdom
| $151K | +$151K | +107,827 | New |
|
|
BBA
4
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
| – | -$6.58K | -960 | Closed |
|
|
5
Jane Street
New York
| – | -$4.07K | -529 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$28 | -4 | Closed |
|